# Lenalidomide in Treating Patients With Relapsed Mycosis Fungoides/Sezary Syndrome

> **NCT00466921** · PHASE2 · COMPLETED · sponsor: **Northwestern University** · enrollment: 33 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **DRUG:** lenalidomide

## Key facts

- **NCT ID:** NCT00466921
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04-19
- **Primary completion:** 2010-04-05
- **Final completion:** 2013-05-17
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2020-12-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00466921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00466921, "Lenalidomide in Treating Patients With Relapsed Mycosis Fungoides/Sezary Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00466921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*